XML 54 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash Flows From Operating Activities:    
Net income (loss) $ (1,762,091) $ 670,222
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:    
Depreciation and amortization 732,702 678,010
Gain on tax settlement 0 (443,110)
Gain on plant acquisition 0 (1,500,000)
Amortization of loan discount 54,110 63,360
Accretion of asset retirement obligation 4,611 4,611
Common stock issued for services 136,000 0
Common stock payable for directors fees 96,875 131,250
Foreign exchange (gain) loss 0 0
Other non cash items (598) (681)
Change in:    
Accounts receivable, net 115,451 (211,637)
Inventories 47,187 197,813
Other current assets 0 4,697
IVA receivable and other assets 39,501 (91,592)
Accounts payable 134,237 28,619
Accrued payroll, taxes and interest 41,325 (49,984)
Deferred revenue 0 (27,649)
Other accrued liabilities 47,465 161,486
Payables to related party 29,683 33,669
Net cash provided (used) by operating activities (283,542) (350,916)
Cash Flows From Investing Activities:    
Purchase of properties, plants and equipment (677,837) (411,571)
Payment received on note receivable - sale of land 400,000 0
Proceeds from plant acquisition 0 1,500,000
Net cash provided (used) by investing activities (277,837) 1,088,429
Cash Flows From Financing Activities:    
Net proceeds from (payments to) factor 42,580 5,168
Checks issued and payable (14,777) 13,572
Stock issued for cash 431,322 0
Advances from related parties 237,400 125,000
Payment on advances from related party (17,387) (125,000)
Advances from notes payable to bank 14,311 (92,565)
Principal payments on long-term debt (116,961) (178,504)
Net cash provided (used) by financing activities 576,488 (252,329)
NET INCREASE IN CASH AND CASH EQUIVALENTS 15,109 485,184
Cash and cash equivalents and restricted cash at beginning of period 113,897 91,332
Cash and cash equivalents and restricted cash at end of period 129,006 576,516
Noncash investing and financing activities:    
Common stock payable issued to directors $ 175,000 $ 175,000